Parsons Capital Management’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $126K | Sell |
32,692
-40,000
| -55% | -$146K | 0.01% | 517 |
|
|
2026
Q1 | $287K | Sell |
72,692
-2,582
| -3% | -$13K | 0.01% | 425 |
|
|
2025
Q4 | $510K | Sell |
75,274
-21,500
| -22% | -$151K | 0.03% | 323 |
|
|
2025
Q3 | $675K | Sell |
96,774
-45,000
| -32% | -$313K | 0.04% | 284 |
|
|
2025
Q2 | $866K | Sell |
141,774
-4,875
| -3% | -$32.4K | 0.05% | 259 |
|
|
2025
Q1 | $1.11M | Sell |
146,649
-20,500
| -12% | -$171K | 0.06% | 238 |
|
|
2024
Q4 | $1.61M | Sell |
167,149
-23,497
| -12% | -$183K | 0.09% | 188 |
|
|
2024
Q3 | $1.13M | Sell |
190,646
-26,500
| -12% | -$176K | 0.07% | 223 |
|
|
2024
Q2 | $1.5M | Sell |
217,146
-10,000
| -4% | -$70.3K | 0.1% | 181 |
|
|
2024
Q1 | $1.75M | Hold |
227,146
| – | – | 0.12% | 165 |
|
|
2023
Q4 | $1.99M | Hold |
227,146
| – | – | 0.14% | 149 |
|
|
2023
Q3 | $1.66M | Sell |
227,146
-30,359
| -12% | -$226K | 0.13% | 154 |
|
|
2023
Q2 | $1.7M | Sell |
257,505
-136,700
| -35% | -$697K | 0.13% | 155 |
|
|
2023
Q1 | $1.34M | Sell |
394,205
-5,630
| -1% | -$21.8K | 0.11% | 174 |
|
|
2022
Q4 | $1.11M | Sell |
399,835
-225,625
| -36% | -$675K | 0.09% | 191 |
|
|
2022
Q3 | $1.79M | Sell |
625,460
-18,662
| -3% | -$66.3K | 0.16% | 129 |
|
|
2022
Q2 | $2.23M | Sell |
644,122
-51,159
| -7% | -$200K | 0.2% | 110 |
|
|
2022
Q1 | $3.27M | Sell |
695,281
-8,500
| -1% | -$41.6K | 0.25% | 92 |
|
|
2021
Q4 | $4.25M | Sell |
703,781
-32,226
| -4% | -$224K | 0.3% | 75 |
|
|
2021
Q3 | $4.46M | Sell |
736,007
-56,783
| -7% | -$640K | 0.35% | 68 |
|
|
2021
Q2 | $9.92M | Sell |
792,790
-28,697
| -3% | -$311K | 0.76% | 24 |
|
|
2021
Q1 | $8.46M | Sell |
821,487
-50,000
| -6% | -$483K | 0.69% | 27 |
|
|
2020
Q4 | $7.91M | Buy |
+871,487
| New | +$6.27M | 0.68% | 29 |
|
|
2018
Q4 | – | Sell |
-492,720
| Closed | -$3.04M | – | 348 |
|
|
2018
Q3 | $3.04M | Buy |
492,720
+8,810
| +2% | +$39.8K | 0.32% | 80 |
|
|
2018
Q2 | $3.09M | Buy |
483,910
+14,273
| +3% | +$102K | 0.35% | 76 |
|
|
2018
Q1 | $3.27M | Buy |
469,637
+56,485
| +14% | +$658K | 0.38% | 68 |
|
|
2017
Q4 | $5.21M | Buy |
413,152
+56
| +0% | +$683 | 0.58% | 39 |
|
|
2017
Q3 | $4.91M | Buy |
413,096
+469
| +0.1% | +$6.96K | 0.58% | 41 |
|
|
2017
Q2 | $6.18M | Sell |
412,627
-206,173
| -33% | -$2.75M | 0.75% | 30 |
|
|
2017
Q1 | $5.9M | Sell |
618,800
-103,500
| -14% | -$874K | 0.75% | 31 |
|
|
2016
Q4 | $6.4M | Sell |
722,300
-5,000
| -0.7% | -$44.9K | 0.85% | 24 |
|
|
2016
Q3 | $6.24M | Buy |
727,300
+50
| +0% | +$396 | 0.84% | 28 |
|
|
2016
Q2 | $5.8M | Buy |
727,250
+2,550
| +0.4% | +$19.8K | 0.79% | 29 |
|
|
2016
Q1 | $6.33M | Buy |
724,700
+6,000
| +0.8% | +$49.9K | 0.87% | 23 |
|
|
2015
Q4 | $6.73M | Buy |
718,700
+10,650
| +2% | +$92.3K | 0.95% | 17 |
|
|
2015
Q3 | $6.83M | Sell |
708,050
-5,250
| -0.7% | -$55.4K | 1% | 14 |
|
|
2015
Q2 | $8.27M | Buy |
713,300
+3,150
| +0.4% | +$32.4K | 1.1% | 13 |
|
|
2015
Q1 | $7.39M | Sell |
710,150
-4,799
| -0.7% | -$44.9K | 1.04% | 13 |
|
|
2014
Q4 | $8.24M | Sell |
714,949
-9,400
| -1% | -$92.9K | 1.09% | 14 |
|
|
2014
Q3 | $5.17M | Buy |
724,349
+2,000
| +0.3% | +$13.9K | 0.71% | 30 |
|
|
2014
Q2 | $5.12M | Sell |
722,349
-12,500
| -2% | -$73.2K | 0.7% | 33 |
|
|
2014
Q1 | $4.5M | Buy |
734,849
+35,850
| +5% | +$263K | 0.64% | 39 |
|
|
2013
Q4 | $6.11M | Buy |
698,999
+2,400
| +0.3% | +$14.7K | 0.92% | 20 |
|
|
2013
Q3 | $2.9M | Sell |
696,599
-2,900
| -0.4% | -$16K | 0.48% | 54 |
|
|
2013
Q2 | $4.94M | Buy |
+699,499
| New | +$4.89M | 0.85% | 26 |
|
Other funds holding MDXG
OAM
IP
AW
SO
TCWA
AHL
DADC
ECM
Parsons Capital Management's MDXG Position: Q2 2026 in Review
Parsons Capital Management reduced its MiMedx Group (MDXG) stake by 55% in Q2 2026, selling an estimated $146K and leaving 32,692 shares worth $126K. The position accounts for 0.01% of the portfolio, ranked #517.
Parsons Capital Management first reported a position in MDXG in Q2 2013 and has held it in 45 quarters since. The position peaked at $9.92M in Q2 2021. 47 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.
- Parsons Capital Management held 32,692 shares of MiMedx Group worth $126K as of Q2 2026.
- Parsons Capital Management sold 40,000 MiMedx Group shares in Q2 2026, an estimated $146K.
- MiMedx Group made up 0.01% of Parsons Capital Management's portfolio in Q2 2026, its #517 holding.
- Parsons Capital Management first reported a position in MiMedx Group in Q2 2013 and has held it in 45 quarters since.
- Parsons Capital Management's MiMedx Group position peaked at $9.92M in Q2 2021.
- 47 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.
Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.